# Chronic Pain Risk Associated With Menstrual Period Pain

> **NCT02214550** · PHASE4 · COMPLETED · sponsor: **Endeavor Health** · enrollment: 353 (actual)

## Conditions studied

- Cystitis, Interstitial
- Dysmenorrhea
- Migraine Disorders
- Pelvic Pain
- Endometriosis
- Visceral Pain
- Chronic Pain

## Interventions

- **DRUG:** cyclic microgestin 1/20
- **DRUG:** continuous microgestin 1/20

## Key facts

- **NCT ID:** NCT02214550
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2020-11
- **Final completion:** 2021-01
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02214550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02214550, "Chronic Pain Risk Associated With Menstrual Period Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02214550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*